Document is current
Any future updates will be listed below
-
Authors
Zander, Thilo https://orcid.org/0000-0003-3691-7497
Pabst, Thomas https://orcid.org/0000-0002-6055-5257
Schär, Sämi https://orcid.org/0000-0001-6108-4832
Aebi, Stefan
Mey, Ulrich
Novak, Urban
Lerch, Erika
Rhyner Agocs, Gaëlle
Goede, Jeroen
Maniecka, Zuzanna
Hayoz, Stefanie https://orcid.org/0000-0002-2265-6559
Rüfer, Axel
Renner, Christoph
Driessen, Christoph
-
Funding
Funding for this research was provided by:
Krebsliga Schweiz (KFS-4564-08-2018)
Swiss Group for Clinical Cancer Research (SAKK) LOA IV funds (managed by curafutura, santésuisse, pharma suisse) Swiss State Secreteriat of Education, Research and Innovation
- License Information
-
More Information
Article History
Received: 12 September 2022
Revised: 21 December 2022
Accepted: 4 January 2023
First Online: 12 January 2023
Competing interests
: The authors declare no competing interests.
